Pill-ow talk: The Tipline for 14 June 2022

Harold Stephens was likely not too worried about the impacts of consolidation in the pharmaceutical industry when he became the first head of the Department of Justice’s antitrust division on this date in 1933. The topic is a little more top-of-mind for assistant attorney general Jonathan Kanter today as he and Federal Trade Commission chair Lina Khan kick off a two-day workshop looking for new ways to challenge acquisitions of drug companies.

Get unlimited access to all Global Competition Review content